DOI: 10.1055/s-00000054

Pharmacopsychiatry

Issue S 1 · Volume 31 · June 1998 DOI: 10.1055/s-002-6320

Editorial

  • 1
    Müller, Walter E.:

    St. Johns Wort (Hypericum), the Story Goes on

    • Original Paper

  • 2
    Erdelmeier, C. A. J.:

    Hyperforin, Possibly the Major Non-Nitrogenous Secondary Metabolite of Hypericum perforatum L.

  • 7
    Chatterjee, S. S.; Nöldner, M.; Koch, E.; Erdelmeier, C.:

    Antidepressant Activity of Hypericum Perforatum and Hyperforin: the Neglected Possibility

  • 16
    Müller, W. E.; Singer, A.; Wonnemann, M.; Hafner, U.; Rolli, M.; Schäfer, C.:

    Hyperforin Represents the Neurotransmitter Reuptake Inhibiting Constituent of Hypericum Extract

  • 22
    Bhattacharya, S. K.; Chakrabarti, A.; Chatterjee, S. S.:

    Activity Profiles of Two Hyperforin-Containing Hypericum Extracts in Behavioral Models

  • 30
    Dimpfel, W.; Schober, F.; Mannel, M.:

    Effects of a Methanolic Extract and a Hyperforin-Enriched CO2 Extract of St. John's Wort (Hypericum perforatum) on Intracerebral Field Potentials in the Freely Moving Rat (Tele-Stereo-EEG)

  • 36
    Biber, A.; Fischer, H.; Römer, A.; Chatterjee, S. S.:

    Oral Bioavailability of Hyperforin from Hypericum Extracts in Rats and Human Volunteers

  • 44
    Schellenberg, R.; Sauer, S.; Dimpfel, W.:

    Pharmacodynamic Effects of two Different Hypericum Extracts in Healthy Volunteers Measured by Quantitative EEG

  • 54
    Laakmann, G.; Schüle, C.; Baghai, T.; Kieser, M.:

    St. John's Wort in Mild to Moderate Depression: The Relevance of Hyperforin for the Clinical Efficacy